{
    "code": 0,
    "data": [
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Financial Results as on 31st December 2025",
            "news_id": "3e6488ed-c234-4f29-8c77-21dc2815e6d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=192222ad-bc7b-46e3-9a0a-49b54095fd81.pdf",
            "news_date": "2026-01-31 19:41:45",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Financial Results as on 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=192222ad-bc7b-46e3-9a0a-49b54095fd81.pdf",
            "news_date": "2026-01-31 19:41:45"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Issue of Duplicate Share Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=248c8164-040c-4beb-b76f-15013322ab52.pdf",
            "news_date": "2026-01-31 16:24:43"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Financial Results as on 31st December 2025.",
            "news_id": "e15c1024-cd84-4f10-bc8d-54ffaa88b35e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6e8bd59-da99-4715-a755-4b13de1cc32a.pdf",
            "news_date": "2026-01-31 15:59:39",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Financial Results as on 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6e8bd59-da99-4715-a755-4b13de1cc32a.pdf",
            "news_date": "2026-01-31 15:59:39"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Financial Results As On 31St December 2025.",
            "news_body": "Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 inter alia to consider and approve  Financial Results as on 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57e8efb2-7dea-407b-b975-f294c23339a6.pdf",
            "news_date": "2026-01-24 19:28:03"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Reg 74",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9dc38e1-c760-40f5-84aa-697a6ac95346.pdf",
            "news_date": "2026-01-20 17:37:53"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Tapovan Paper and Board Mills Ltd & Others",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=AFD13899_D3C9_4952_B6C6_FD7A24CA8261_174109.pdf",
            "news_date": "2026-01-13 17:41:14"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f67f84cf-d75e-4fa9-8aaa-3b8921eeb55d.pdf",
            "news_date": "2025-12-27 17:53:25"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "c3cf59f4-1e78-49a6-8422-1bfccb5d644e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0665acc-bf43-47b6-8ad1-be7500909784.pdf",
            "news_date": "2025-11-18 17:16:11",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0665acc-bf43-47b6-8ad1-be7500909784.pdf",
            "news_date": "2025-11-18 17:16:11"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results as on 30th September 2025.",
            "news_id": "a8c50ddf-ab0f-4525-95a9-816d9cae49e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b71106d-3520-4e8a-a096-586f91bbdee6.pdf",
            "news_date": "2025-11-14 10:32:44",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results as on 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b71106d-3520-4e8a-a096-586f91bbdee6.pdf",
            "news_date": "2025-11-14 10:32:44"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 30Th September 2025",
            "news_body": "Outcome of Board Meeting",
            "news_id": "4212a0a8-cc98-450b-afc2-e5e775134442",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9b160e1-c286-4073-bab5-3edbf5f2e132.pdf",
            "news_date": "2025-11-13 18:08:11",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results As On 30Th September 2025",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9b160e1-c286-4073-bab5-3edbf5f2e132.pdf",
            "news_date": "2025-11-13 18:08:11"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Unaudited Financial Results as on 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb8145a9-8a28-4b95-8c14-20b6de7b766d.pdf",
            "news_date": "2025-11-13 18:04:54"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Earning Conference Call",
            "news_body": "The Earning conference call of the Company is scheduled to be held on Friday 14th November 2025 at 12:30 PM IST.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e6fd202-3e73-43a3-9228-2c4f0424a620.pdf",
            "news_date": "2025-11-10 15:40:33"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Financial Results As On 30Th Sept 2025",
            "news_body": "Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Financial results as on 30th Sept 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=785d32c9-c7d8-4eaa-b8c1-da7d2773efff.pdf",
            "news_date": "2025-11-06 17:16:10"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under 74(5) of SEBI (DP) Regulation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=886c3a33-7fd5-43df-b3e2-3d61ea4f100e.pdf",
            "news_date": "2025-10-15 16:01:33"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "32nd Annual General Meeting of Nath Bio-Genes (India) Limited held today on 22nd August 2025 Pursuant to Regulation 30 and Regulation  44. Please find the following.\r\n\r\n1. Proceedings of Annual General Meeting.\r\n2. Voting Results.\r\n3. Scrutinizers Report.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08945ca1-f071-4e32-b4d5-ad370b440f74.pdf",
            "news_date": "2025-08-22 17:26:37"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45dbae9b-a963-4ca5-af94-0a15f9f3e3e4.pdf",
            "news_date": "2025-07-31 21:15:00"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Thursday 14Th August 2025",
            "news_body": "Record date for the purpose of Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f0799c3-95a3-4ea9-b078-8d811ff5132a.pdf",
            "news_date": "2025-07-31 20:55:56"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Friday 22Nd August 2025",
            "news_body": "Notice of 32nd Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e08a98d-03e8-42b0-9d3c-862c4cb31177.pdf",
            "news_date": "2025-07-31 20:54:02"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Reg 74(5) of SEBI_ DP Regulation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fdadf6e-a07a-4e27-aa32-bb9f001125d6.pdf",
            "news_date": "2025-07-16 17:09:05"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results as on 30th June 2025",
            "news_id": "d222a32f-40e1-4e47-8160-7aaab56a8457",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcd6f28d-7fd0-46e4-8e91-7a24921e6346.pdf",
            "news_date": "2025-07-11 17:11:39",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results as on 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcd6f28d-7fd0-46e4-8e91-7a24921e6346.pdf",
            "news_date": "2025-07-11 17:11:39"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results As On 30Th June 2025.",
            "news_body": "The Board of Directors of the Company at Meeting held today on 11th July 2025 has approved the following\r\n\r\n1. Stanaldone and Consolidated Financial Results as on 30th June 2025.\r\n\r\n2. Appointment of Ms. Payal Jain as Additional Director (Independent) of the Company.",
            "news_id": "71e28751-a625-494d-919c-0fef00989903",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d939bbdd-7d77-48c2-832d-9f0a982c8cd2.pdf",
            "news_date": "2025-07-11 16:44:53",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results As On 30Th June 2025.",
            "news_body": "The Board of Directors of the Company at Meeting held today on 11th July 2025 has approved the following\r\n\r\n1. Stanaldone and Consolidated Financial Results as on 30th June 2025.\r\n\r\n2. Appointment of Ms. Payal Jain as Additional Director (Independent) of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d939bbdd-7d77-48c2-832d-9f0a982c8cd2.pdf",
            "news_date": "2025-07-11 16:44:53"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The 30Th June 2025",
            "news_body": "Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2025 inter alia to consider and approve unaudited financial results as on 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8576364b-2ffc-458d-ba32-199d928e641a.pdf",
            "news_date": "2025-07-04 12:41:29"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Resignation of Additional Director (Independent).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=170cd529-872a-4a8f-a555-bcc4bc4093b6.pdf",
            "news_date": "2025-07-03 15:16:36"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16bd8948-d445-4148-bd40-25ae40a3dcaf.pdf",
            "news_date": "2025-06-27 12:45:25"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 11 2025 for Ferry Fax Farms Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=EA81DF7F_35DB_455B_AE4C_B6223936F041_134253.pdf",
            "news_date": "2025-06-11 13:43:02"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Issue of Duplicate Share Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7baed368-f0d7-4a50-8af2-bf039309f705.pdf",
            "news_date": "2025-06-03 16:37:09"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4decf5fc-b493-46d1-8f70-1a0518cb2acf.pdf",
            "news_date": "2025-05-30 12:10:11"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation for issue of Duplicate Share Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9eaaa65a-878e-4b6f-a295-981baed5e72e.pdf",
            "news_date": "2025-05-21 16:30:47"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditya Birla Sun Life Mutual Fund",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E7190A7F_A291_4EFA_BDAC_3379FA8EB452_145956.pdf",
            "news_date": "2025-05-15 15:00:00"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning call held on 30th April 2025",
            "news_id": "b3340bc6-2dde-45b6-9281-5c596e486d6c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc494e73-2aa0-458c-989b-3eac83338a68.pdf",
            "news_date": "2025-05-02 16:32:59",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning call held on 30th April 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc494e73-2aa0-458c-989b-3eac83338a68.pdf",
            "news_date": "2025-05-02 16:32:59"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Director",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
            "news_body": "Revised Disclosure for Resignation of Ms. Ashu Jain from the post of Independent Director of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccd5b95b-77c3-4a3b-895d-bf8657dc76fd.pdf",
            "news_date": "2025-05-02 15:00:44"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results as on 31st March 2025",
            "news_id": "4de9af20-d95f-418c-8899-1787894d9eab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e53f526-d9c4-4959-aead-af1a06a071d2.pdf",
            "news_date": "2025-04-29 18:02:48",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results as on 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e53f526-d9c4-4959-aead-af1a06a071d2.pdf",
            "news_date": "2025-04-29 18:02:48"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 31St March 2025",
            "news_body": "The Board in the meeting held today on 29th April 2025 has approved the Standalone and Consolidated Financial Results as on 31st Match 2025.",
            "news_id": "8187b57c-7a38-46e4-ad45-5d69b447d7d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07c82f86-ba38-4f7e-95bb-ebd92fa7732d.pdf",
            "news_date": "2025-04-29 17:48:03",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results As On 31St March 2025",
            "news_body": "The Board in the meeting held today on 29th April 2025 has approved the Standalone and Consolidated Financial Results as on 31st Match 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07c82f86-ba38-4f7e-95bb-ebd92fa7732d.pdf",
            "news_date": "2025-04-29 17:48:03"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "The Board on meeting held today on 29th April 2025 has approved the following.\r\n\r\n1. Standalone Audited Financial Results as on 31st March 2025 along with Auditors Report \r\n2. Consolidated Audited Financial Results as on 31st March 2025 along with Auditors Report \r\n3. Other Disclosure/ Announcements.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62ac9c75-4595-4b86-a372-cf90fbfa4224.pdf",
            "news_date": "2025-04-29 17:42:10"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Earning Conference Call.",
            "news_body": "Intimation of Con Call to be held on 30th April 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e540353-62d5-4bb1-ae04-a72bf70dac7c.pdf",
            "news_date": "2025-04-24 11:17:51"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended 31St March 2025",
            "news_body": "Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2025 inter alia to consider and approve Audited Financial Results for the quarter and financial year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f418f445-1c56-4f29-ba29-f592fbdd614a.pdf",
            "news_date": "2025-04-21 17:15:14"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Issue of Duplicate share certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa50b574-3975-46a4-bc0f-2a6b7c4a87bc.pdf",
            "news_date": "2025-04-21 15:13:44"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Reg 74(5) of SEBI DP Regulations- NATHBIOGEN",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18517485-a9b2-4eb1-975a-7c2f4e03d6cb.pdf",
            "news_date": "2025-04-14 17:10:40"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31426abf-dfa6-4dec-8fa2-d8524c812a14.pdf",
            "news_date": "2025-03-27 15:39:53"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results for 31st December 2024.",
            "news_id": "a403ba6a-b52c-469d-9003-63c3272c0160",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cfe9bbf-e808-4dd4-aeef-9a8cf92fd2e3.pdf",
            "news_date": "2025-01-25 20:29:34",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results for 31st December 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cfe9bbf-e808-4dd4-aeef-9a8cf92fd2e3.pdf",
            "news_date": "2025-01-25 20:29:34"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome of Board Meeting",
            "news_body": "Nath Bio-Genes (India) Ltd has informed BSE regarding Outcome of Board Meeting held on January 23 2025.",
            "news_id": "b8d5561b-1703-4e09-ad79-841cd079e603",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=813CC6BA-E627-45AB-BE90-66B138B02B3B-170502.pdf",
            "news_date": "2025-01-23 17:05:06",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome of Board Meeting",
            "news_body": "Nath Bio-Genes (India) Ltd has informed BSE regarding Outcome of Board Meeting held on January 23 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=813CC6BA-E627-45AB-BE90-66B138B02B3B-170502.pdf",
            "news_date": "2025-01-23 17:05:06"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The Period Ended 31St December 2024",
            "news_body": "Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve unaudited financial results for the period ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32795c54-f3a9-47fe-b60f-af757e67e562.pdf",
            "news_date": "2025-01-15 16:45:38"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulations 2018 for the period ended 31st December 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ed8d8d7-a333-42a7-ab55-7fc9b335377e.pdf",
            "news_date": "2025-01-14 15:21:15"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation for Loss of Share Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78251e4e-aab0-491b-b8a1-b9aa08c96af2.pdf",
            "news_date": "2024-12-06 16:13:57"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Compliance Certificate under Reg 39(3) of SEBI.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fa4b209-8d94-4b00-b988-45de36c18cac.pdf",
            "news_date": "2024-11-28 16:39:56"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call held on 24th October 2024.",
            "news_id": "8b1e94fb-a4bd-4bff-9684-a1075247da39",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=846f5ad3-7416-4e0c-a6c6-03c43c762c71.pdf",
            "news_date": "2024-10-28 19:10:07",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call held on 24th October 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=846f5ad3-7416-4e0c-a6c6-03c43c762c71.pdf",
            "news_date": "2024-10-28 19:10:07"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91c8fe46-d4df-42fb-b833-12f3e25d708a.pdf",
            "news_date": "2024-10-28 15:43:19"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio Transcript of Earning Call held on 24th October 2024",
            "news_id": "1b64b54f-1f94-4ebc-b659-4b3fc06c0638",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=554ed23a-62ca-423a-beb6-9718a73512d7.pdf",
            "news_date": "2024-10-25 17:32:13",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio Transcript of Earning Call held on 24th October 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=554ed23a-62ca-423a-beb6-9718a73512d7.pdf",
            "news_date": "2024-10-25 17:32:13"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited financial results as on 30th Sept 2024.",
            "news_id": "88556116-4bf7-4470-a03c-5ca6767340b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fda3214-99d1-43a1-98ef-61bd83debb58.pdf",
            "news_date": "2024-10-23 17:34:07",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited financial results as on 30th Sept 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fda3214-99d1-43a1-98ef-61bd83debb58.pdf",
            "news_date": "2024-10-23 17:34:07"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Change in Chief Financial Officer of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8bf4eca7-5a8e-4f10-893e-5cfb342d0dae.pdf",
            "news_date": "2024-10-23 16:35:37"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Unaudited financial results as on 30th Sept 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c535ed12-4957-4a8c-ab3f-efbb3c91c527.pdf",
            "news_date": "2024-10-23 16:33:27"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results As On 30Th Sept 2024",
            "news_body": "Outcome of Board Meeting",
            "news_id": "f56ef942-1e4d-4697-8a67-f19829da8875",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6086d580-4cc8-470a-99c6-460067cee4b7.pdf",
            "news_date": "2024-10-23 16:31:07",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results As On 30Th Sept 2024",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6086d580-4cc8-470a-99c6-460067cee4b7.pdf",
            "news_date": "2024-10-23 16:31:07"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of conference call to be held on 24th October 2024 at 05:00 PM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62a5584e-ab93-47ca-9733-0e8a931f8170.pdf",
            "news_date": "2024-10-19 11:13:18"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2024.",
            "news_body": "Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 ,inter alia, to consider and approve unaudited financial results for the quarter and half year ended 30th September 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84449616-a1d4-4aaf-a69d-140ca1c09f8c.pdf",
            "news_date": "2024-10-17 11:57:51"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18cfe83e-198f-46c2-8e8d-96da2318579e.pdf",
            "news_date": "2024-09-27 16:48:42"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Details of Loss of Share Certificate of Shareholder",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a63a58b-89bd-4163-ad97-8eed0ff2bd6b.pdf",
            "news_date": "2024-08-22 15:28:09"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer''s Report",
            "news_body": "The Annual General Meeting of the Company held today on 17th August 2024, at 11:00 AM.please find the attached 1. Proceedings of Annual General Meeting 2. Voting results 3. Scrutinizers Report for Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=197426f0-ff46-45a5-bec9-a3246f72f3f0.pdf",
            "news_date": "2024-08-17 15:44:44"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Outcome of 31st Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29e5a519-225e-4946-9825-9c84e4974193.pdf",
            "news_date": "2024-08-17 12:24:03"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Details of Loss of Share Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c814e96d-3800-40de-9bb0-dda124893daa.pdf",
            "news_date": "2024-08-09 17:06:49"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited Financial results as on 30th June 2024",
            "news_id": "4c5d7a42-fa43-4ea5-971c-530ebf96d6e8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5666baaa-6018-49fc-8dc3-aa6f07e67334.pdf",
            "news_date": "2024-08-07 22:13:21",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited Financial results as on 30th June 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5666baaa-6018-49fc-8dc3-aa6f07e67334.pdf",
            "news_date": "2024-08-07 22:13:21"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results As On 30Th June 2024",
            "news_body": "Outcome of Board Meeting",
            "news_id": "af2bf93a-71f0-403e-be2d-ea59688a304a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66770976-1c09-4201-b875-50ecb11a2959.pdf",
            "news_date": "2024-08-07 15:48:38",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results As On 30Th June 2024",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66770976-1c09-4201-b875-50ecb11a2959.pdf",
            "news_date": "2024-08-07 15:48:38"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 07Th August 2024.",
            "news_body": "Unaudited financial results as at 30th June 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1decdf46-5ad0-49f4-8fb9-6c96e42012d7.pdf",
            "news_date": "2024-08-07 15:44:17"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Financial Results As On 30Th June 2024.",
            "news_body": "Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 ,inter alia, to consider and approve Unaudited financial results as on 30th June 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84d82cba-21c7-4b6d-b9d2-12b32e6742af.pdf",
            "news_date": "2024-07-30 15:03:17"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Corp. Action",
            "descriptor": "Record Date",
            "caption": "Record Date",
            "news_body": "Record date for AGM and Dividend is Friday 09th August 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77203715-f264-44f7-88a0-fed78164481f.pdf",
            "news_date": "2024-07-23 17:46:08"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the financial year 2023-24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c493a3ec-c610-463b-a26d-86a3ee2f30f0.pdf",
            "news_date": "2024-07-23 17:44:26"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Notice Of Annual General Meeting",
            "news_body": "Notice of Annual General Meeting and Annual Report for the financial year 2023-24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00e98cc1-ee0d-4f56-9bb5-562b5f25637c.pdf",
            "news_date": "2024-07-23 17:37:55"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b90b8ab5-00ef-4162-bec5-101e254114c0.pdf",
            "news_date": "2024-07-13 16:22:46"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=300cd371-c997-4c87-98bf-a3d2c489bc04.pdf",
            "news_date": "2024-06-29 15:42:15"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Compliance under Reg 39 (3) for Details of Loss of Share Certificate.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9930cac2-324c-44e8-b9be-f5642671fbd1.pdf",
            "news_date": "2024-06-14 11:05:00"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for  FY 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6059b8a1-1055-40e6-b350-fb37bfa3104f.pdf",
            "news_date": "2024-05-29 17:01:14"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Compliance under Regulation 39(3) of SEBI, LODR Regulations, 2015. for details of loss of share certificate by the shareholder of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=665edc84-a66d-41b5-9a2a-37b78c0341aa.pdf",
            "news_date": "2024-05-28 13:30:09"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call transcript held on 09th May 2024",
            "news_id": "95c36dec-c33b-413d-8fa5-82bbec0f15af",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0b7a82c-d506-4780-ba7c-b714e9a6a677.pdf",
            "news_date": "2024-05-14 14:56:46",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call transcript held on 09th May 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0b7a82c-d506-4780-ba7c-b714e9a6a677.pdf",
            "news_date": "2024-05-14 14:56:46"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call",
            "news_body": "Audio Recording of Conference call held on 09th May 2024 at 04:00 PM on Audited Financial Results of the Company.",
            "news_id": "01515bbc-f004-4094-84b2-db7f4b84487d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0dd2617-c442-4ea3-94a7-b5b5683877e4.pdf",
            "news_date": "2024-05-09 20:07:55",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Audio Recording Of Conference Call",
            "news_body": "Audio Recording of Conference call held on 09th May 2024 at 04:00 PM on Audited Financial Results of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0dd2617-c442-4ea3-94a7-b5b5683877e4.pdf",
            "news_date": "2024-05-09 20:07:55"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Details of Loss of Share Certificate by the Shareholder.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5b29c8d-7d3e-4097-af68-3fd2c9b5afe5.pdf",
            "news_date": "2024-05-09 13:27:03"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results as on 31st March 2024.",
            "news_id": "b53cc7d5-328b-4114-a3c9-49c8519635ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23ea2acb-d43e-43cf-8de1-47ab587d1b9e.pdf",
            "news_date": "2024-05-08 17:29:14",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results as on 31st March 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23ea2acb-d43e-43cf-8de1-47ab587d1b9e.pdf",
            "news_date": "2024-05-08 17:29:14"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 08Th May 2024",
            "news_body": "Outcome of Board meeting held on 08th May 2024 for approval of  1. Audited Financial Results as on 31st March 2024.2. Recommendation of Dividend by Board of Directors 3. Date of Annual General Meeting of the Company for financial year 2023-24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e1e38f-0c5e-4f07-b7a2-157d6ff8e4bb.pdf",
            "news_date": "2024-05-08 17:27:12"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results As At 31St March 2024",
            "news_body": "Outcome of Board Meeting of the Company held on 08th May 2024.",
            "news_id": "517b29f5-8f12-443d-ae46-5a47fa275ff6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e74e136-b51e-4adc-9001-dcb82616033b.pdf",
            "news_date": "2024-05-08 17:19:41",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results As At 31St March 2024",
            "news_body": "Outcome of Board Meeting of the Company held on 08th May 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e74e136-b51e-4adc-9001-dcb82616033b.pdf",
            "news_date": "2024-05-08 17:19:41"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Intimation Of Earing Conference Call",
            "news_body": "Intimation of Earning Conference Call to be held on 09th May at 04:00 PM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1163d222-b23a-4222-82c2-5f57c2fb4331.pdf",
            "news_date": "2024-05-06 17:22:02"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for 1. Approval Of Audited Financial Results For The Year Ended 31St March 2024.",
            "news_body": "Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and approve Audited Financial Results for the year ended 31st March 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0334e2ac-3e81-472f-99c6-84fb850f133a.pdf",
            "news_date": "2024-04-30 15:02:07"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Reg. 40 (10) - PCS Certificate for Transfer / Transmission / Transposition",
            "caption": "Compliance Certificate",
            "news_body": "Compliance Certificate under Regulation 40 (10) of SEBI (LODR) Regulations, 2015, for the period ended 31st March 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=875f53c4-a1ba-4688-819c-33b540aa23cc.pdf",
            "news_date": "2024-04-24 14:51:34"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018, for the period ended 31st March 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76b05a26-75f5-4e30-86ae-1daba4db146d.pdf",
            "news_date": "2024-04-15 13:00:00"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Reg. 7(3) \u2013 Compliance Certificate (RTA & Compliance Officer)",
            "caption": "Compliance Certificate",
            "news_body": "Compliance Certificate under Reg 7(3) of SEBI, (LODR) Regulations for the period ended 31st March 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=123038fb-734b-4aa8-bf09-fd3c98d47b7b.pdf",
            "news_date": "2024-04-12 13:26:39"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015.",
            "news_body": "Inter-se transfer of shares among the Promoters",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d3ce75e-213d-4b30-b07d-c27081e8b834.pdf",
            "news_date": "2024-03-27 15:21:03"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading WIndow",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1d4b9b5-3c09-49c4-a129-0ae49b622060.pdf",
            "news_date": "2024-03-27 13:00:54"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "AGM/EGM",
            "descriptor": "EGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Revised Proceedings of the Extra Ordinary General Meeting of the Company held on 12th March 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6966e59f-a8f1-4dac-a734-c37c3ba72d2c.pdf",
            "news_date": "2024-03-15 13:17:11"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "AGM/EGM",
            "descriptor": "EGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Extra Ordinary General Meeting of the Company held on 12th March 2024 in this regard,Proceedings of the Meetings, Voting Results and Scrutinizers Report is attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0db33324-a563-46a2-aa63-eb0cfac4e3d4.pdf",
            "news_date": "2024-03-13 17:28:24"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "AGM/EGM",
            "descriptor": "EGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
            "news_body": "The outcome of the Extra-ordinary General Meeting of the Company held on 12th March 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d9e1fd4-f6f8-42ef-94a0-e34ca5d50bd8.pdf",
            "news_date": "2024-03-12 12:54:57"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation for Loss of Share Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61586ef6-4398-47dc-9641-e9c5c5b9aa26.pdf",
            "news_date": "2024-03-05 16:37:30"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akash Farms LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9718CCE8_CB14_4AA6_BE05_E8B0DD1128EF_103039.pdf",
            "news_date": "2024-02-22 10:30:43"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Agri-Tech (India) Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7F73B569_6E00_4D21_BDBC_F867013042D7_102801.pdf",
            "news_date": "2024-02-22 10:28:04"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 21, 2024 for Agri-Tech (India) Ltd & Ashu Farms LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=A00FD69E_19E6_4035_803E_F8E93FAB07E7_161522.pdf",
            "news_date": "2024-02-21 16:15:25"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "AGM/EGM",
            "descriptor": "EGM",
            "caption": "Notice Of Extra Ordinary General Meeting",
            "news_body": "Notice of Extra Ordinary General Meeting of the Company to be held on Tuesday 12th March 2024 at 11:00 AM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90804e4c-d85d-4199-ad62-136c8743e3f7.pdf",
            "news_date": "2024-02-16 15:17:51"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the financial results as on 31st December 2023.",
            "news_id": "2b56fade-ae4a-4b8f-8205-6921c809d5f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=299b2362-6a89-4d5d-bb77-d9a13c147809.pdf",
            "news_date": "2024-01-18 18:45:46",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the financial results as on 31st December 2023.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=299b2362-6a89-4d5d-bb77-d9a13c147809.pdf",
            "news_date": "2024-01-18 18:45:46"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On 18Th January 2024.",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0d20807-e886-48f1-a3cc-c11cf990b7c2.pdf",
            "news_date": "2024-01-18 18:32:58"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "The Outcome Of The Meeting Of The Board Of Directors Of The Company Held On 31St December 2023.",
            "news_body": "Outcome of Board Meeting",
            "news_id": "a47f9746-e541-4b06-8a4b-1f3ac113433e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a7cc754-12dc-4d79-8397-d04766a0e3fa.pdf",
            "news_date": "2024-01-18 18:27:29",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "The Outcome Of The Meeting Of The Board Of Directors Of The Company Held On 31St December 2023.",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a7cc754-12dc-4d79-8397-d04766a0e3fa.pdf",
            "news_date": "2024-01-18 18:27:29"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Compliance Certificate under Reg 74(5) of SEBI (DP) Regulation, 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=752fcbf1-1bcf-4bc6-bc1d-a9a16e034d0d.pdf",
            "news_date": "2024-01-14 19:24:46"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results As Of 31St December 2023.",
            "news_body": "Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/01/2024 ,inter alia, to consider and approve Unaudited Financial Results as of 31st December 2023.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d7cd6af-5de3-4ff9-a22d-fc9959ad148e.pdf",
            "news_date": "2024-01-09 22:13:55"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation Regarding Loss of Share Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82ac8e22-32f2-4bb5-a0c8-02b1151e1d63.pdf",
            "news_date": "2023-12-28 14:35:58"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91cec7ca-074b-44f5-955b-a2974c8bb16d.pdf",
            "news_date": "2023-12-28 13:13:29"
        },
        {
            "co_code": 44041,
            "bse_code": 537291,
            "isin": "INE448G01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Barkha Farms LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=079AAC4A_EB4C_4E1A_AD8E_2A8154BCD1C9_140912.pdf",
            "news_date": "2023-12-27 14:09:26"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call held on 17th October 2023",
            "news_id": "5079a103-0c55-4026-96ea-15fd62d1a32b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25037e02-130e-4117-ab1c-7d1be723699c.pdf",
            "news_date": "2023-10-21 10:00:00",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited financial results as of 30th Sept 2023",
            "news_id": "ff4b6200-b8bf-4067-bd40-7e42483a5ade",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d2cc706-307e-402b-99d0-c138b6100578.pdf",
            "news_date": "2023-10-16 18:21:20",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As Of 30Th Sept 2023",
            "news_body": "Unaudited financial results as of 30th Sept 2023",
            "news_id": "310807ac-cb47-4368-b195-f603923019d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af0c0cb8-8256-4d7c-8e3e-44115ab78972.pdf",
            "news_date": "2023-10-16 18:09:21",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results as of 30th June 2023",
            "news_id": "2af4288b-e5e7-4686-924d-be7aa01e3222",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfb2c7f5-f88c-49a1-9201-d8649a222511.pdf",
            "news_date": "2023-08-10 20:33:51",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As Of 30Th June 2023",
            "news_body": "Unaudited quarterly Standalone and Consolidated financial results as on 30th June 2023.",
            "news_id": "4846e2ae-01bf-4394-9828-de86e7454f19",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3bc6f758-b0a7-4ff6-8d35-3a0d1886f357.pdf",
            "news_date": "2023-08-10 17:41:53",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "9bd1da52-145e-444d-99f2-c5cb1dbf1aaf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f2e330e-cdde-4014-b642-3d686352636c.pdf",
            "news_date": "2023-04-27 15:02:07",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results as of 31st March 2023.",
            "news_id": "e69b320b-5541-4eac-91ff-85767f9a44f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=238b954b-cc30-4b88-be90-958522ac64b2.pdf",
            "news_date": "2023-04-22 18:24:41",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results As Of 31St March 2023",
            "news_body": "Audited Financial Results as of 31st March 2023",
            "news_id": "5e7e832d-1954-4762-b5d2-0e264c66a97c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d54addc5-8efa-4a9a-9dd9-cdae824a2e1c.pdf",
            "news_date": "2023-04-22 17:58:25",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited financial results as on 31st December 2022.",
            "news_id": "570698bc-6519-4e87-9e85-d01686dd20a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bee73321-6baa-43b5-870c-9f54b7549ccb.pdf",
            "news_date": "2023-02-14 17:17:26",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results As On 31St December 2022.",
            "news_body": "Unaudited Financial Results as on 31st December 2022.",
            "news_id": "c7bd272f-6457-4daf-bf5c-db28ff2853b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f42e4178-cd22-40d5-a75b-b0afe2f1fcbc.pdf",
            "news_date": "2023-02-14 16:28:24",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Reg 23 (9).",
            "news_body": "Disclosure of Related Party Transactions under Reg 23 (9).",
            "news_id": "21a8a2a5-48e7-4881-a920-7fe0ea864756",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a51ac556-0335-41b8-978e-13e73f5149d2.pdf",
            "news_date": "2022-11-03 17:54:18",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results as on 30.09.2022.",
            "news_id": "e009c36d-e2ca-4921-b036-d357ac1caaf7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4f8bc66-0568-46dc-a579-bb202c18dbeb.pdf",
            "news_date": "2022-10-20 17:07:15",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results As On 30.09.2022",
            "news_body": "Unaudited Financial Results as on 30.09.2022",
            "news_id": "108bfa93-5bb7-4eb6-a69b-687ebd5191a2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e735784-4a7c-4266-af95-bb29e5e86565.pdf",
            "news_date": "2022-10-20 15:43:21",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 30.09.2022",
            "news_body": "Financial Results as on 30.09.2022",
            "news_id": "111b7b45-4620-4d5f-b278-25ebdeda356b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5094955e-9ff5-4601-99be-801e28f320e6.pdf",
            "news_date": "2022-10-20 15:41:18",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter ended on 30th June 2022",
            "news_id": "083f418c-d8c3-4e72-80cd-825ae6fe4a6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb767893-e923-4913-b771-94cc100368f8.pdf",
            "news_date": "2022-08-13 18:46:46",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 30Th June 2022",
            "news_body": "Financial Results as on 30th June 2022",
            "news_id": "57a75981-ba1d-470f-a911-8b6b99788660",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=730e3bb8-3805-4e7b-b6eb-07376fb92dc7.pdf",
            "news_date": "2022-08-13 16:41:49",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23 (9) On Related Party Transaction For The Half-Year Ended 31St March 2022.",
            "news_body": "Disclosure under Regulation 23 (9) on Related Party Transaction for the half-year ended 31st March 2022.",
            "news_id": "10142060-0f4e-49b1-8c11-ab4f94e42d94",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=613062c1-bc2c-448d-b39f-0e08d9817dbf.pdf",
            "news_date": "2022-06-11 16:36:54",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with the Investors/Analysts",
            "news_id": "bbafe5a7-a1df-46d9-b0a9-c532d5d93b1d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a408b07-3366-4348-bba1-aee9f6596845.pdf",
            "news_date": "2022-06-02 11:26:58",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Audited FInancial Results as on 31st March 2022.",
            "news_id": "e624ff83-9187-43da-a4e2-95f4922747d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=645dc102-ab67-46e4-95c9-0340026cfbc6.pdf",
            "news_date": "2022-05-30 16:46:45",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for The Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting held on 30th May 2022.",
            "news_id": "cd1c1958-a992-4d2b-8cae-1258755d4bfb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=718de040-28da-40ea-bd49-24bb557a3b9e.pdf",
            "news_date": "2022-05-30 16:18:48",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results As On 31St March 2022",
            "news_body": "Audited Financial Results as on 31st March 2022",
            "news_id": "d968508f-fa04-49b2-b305-7b1b1a39bb90",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec39a129-35e6-4b8a-ad10-16bbb1728f72.pdf",
            "news_date": "2022-05-30 16:15:34",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on unaudited financial results as on 31st December 2021",
            "news_id": "a84e283e-d8e8-4b3a-919d-5458a51880f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2af4ac37-c5e7-41d9-b91b-53cd91273bdd.pdf",
            "news_date": "2022-02-14 18:30:46",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results As On 31St December 2021.",
            "news_body": "Financial Results as on 31st December 2021.",
            "news_id": "4287252d-b1da-4363-a6e5-87a2228103e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da9bb935-d14a-42ec-b119-56754343bf06.pdf",
            "news_date": "2022-02-11 16:19:14",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 31St December 2021",
            "news_body": "Financial Results as on 31st December 2021.",
            "news_id": "01265ae7-11e4-4996-95a4-68e1b279bc78",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44f69550-a323-4f25-8adc-89fcd550b827.pdf",
            "news_date": "2022-02-11 16:17:37",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call held on 02/11/2021",
            "news_id": "f063f71d-8b3f-4943-a650-5dde6620521e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73656d78-e895-4816-ba93-56a3e804edb3.pdf",
            "news_date": "2021-11-08 16:04:55",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation of financial results as on 30.09.2021",
            "news_id": "313e00dd-57e5-4fef-98d4-614db878beba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd3bcb75-98f5-46ee-8534-5e2bb6037b93.pdf",
            "news_date": "2021-11-01 16:51:04",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results For The Period Ended 30Th Sept 2021",
            "news_body": "Financial Results for the period ended 30th Sept 2021",
            "news_id": "d0045b5a-1ef9-4801-9886-0e86a1748ed0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dac2aaf-23cb-4bc5-ab87-bb50407488f8.pdf",
            "news_date": "2021-11-01 16:26:09",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Period Ended 30Th Sept 2021",
            "news_body": "Financial Results for the period ended 30th Sept 2021",
            "news_id": "abcd7548-c4dd-43bd-928e-d174498402dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3178fdee-97ab-42aa-a7d1-1465c2028f50.pdf",
            "news_date": "2021-11-01 16:24:35",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "315a2cf5-025a-4ef3-964d-c600cbdc02ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac9e9595-d649-4384-afc0-6a491af2ff28.pdf",
            "news_date": "2021-08-17 17:18:44",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited financial results as on 30th June 2021",
            "news_id": "29ef3045-431f-48f5-9cb6-156eaeead436",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d79807a8-3738-4331-b2c9-71928fddc949.pdf",
            "news_date": "2021-08-10 18:34:45",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 30Th June 2021",
            "news_body": "Financial Results as on 30th June 2021",
            "news_id": "dcc78a06-76b2-4e00-844c-52733607d19d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d21a28f1-f188-4c6f-9888-d5f92babdf43.pdf",
            "news_date": "2021-08-10 17:11:51",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirement)Regulation 2015.",
            "news_body": "Disclosure of Related Party Transaction under regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirement)Regulation 2015.",
            "news_id": "eaa22ea3-cddb-4ec8-83f8-77ac4d2e05b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d8d3fdf-0456-4a22-97c1-68577ec38639.pdf",
            "news_date": "2021-07-22 12:12:05",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call held on 25th June 2021.",
            "news_id": "99df137f-a195-4a88-ac75-3faa65a0b118",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=763ccb17-e470-442b-a812-6447510be3c9.pdf",
            "news_date": "2021-07-01 13:11:17",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results as on 31st March 2021.",
            "news_id": "bebb5c3e-8263-4ece-b4c6-e506a6dc896e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec165a70-fbd5-41c9-ba15-780d6217e3d4.pdf",
            "news_date": "2021-06-24 16:58:01",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results As On 31St March 2021",
            "news_body": "Audited Financial Results as on 31st March 2021",
            "news_id": "48e41849-d1f0-4f4c-b731-7ee1da5bece0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=128c086b-d117-4795-befc-fb1496433375.pdf",
            "news_date": "2021-06-24 16:22:47",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Con Call held on 12th February 2021",
            "news_id": "84214e99-c94c-497b-9c6f-8abdbc60b238",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef8bee27-e345-4268-8b6e-714875a57ce2.pdf",
            "news_date": "2021-02-17 16:20:58",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}